Brief: Enochian Biosciences Achieves Full Compliance With NASDAQ Filing Requirements
13/03/2023 12:52
March 13 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES ACHIEVES FULL COMPLIANCE WITH NASDAQ
FILING
REQUIREMENTS
Source text for Eikon: ID:nGNE5QMHqY
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing